Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-25 @ 4:57 AM
NCT ID:
NCT03385018
Eligibility Criteria:
Inclusion Criteria:
* Patients who are over 20 and below 80 years old
* Patients who have performance status of ECOG 0 or 1
* Patients with American Society of Anesthesiology score of class I to III
* Patients who are diagnosed with gastric adenocarcinoma not involving Z-line by endoscopy with biopsy
* Patients with tumors which can be curatively resected by total gastrectomy with lymph node dissection based on preoperative study
* Patients who have primary gastric carcinoma invaded into over muscle propria, and not into adjacent organ in preoperative studies (cT2 \~ cT4a)
* Patients who have no metastasis to lymph nodes or limited metastasis to perigastric lymph node metastasis in preoperative studies (cN0 \~ cN2)
* Patients who agree with participating in the clinical study with informed consents
* Patients who can be followed for at least 3 years after study enrollment
Exclusion Criteria:
* Patients who have possibility of distant metastasis in preoperative studies
* Patients who have history of gastric resection with any cause
* Patients who have complications (bleeding or obstruction) of gastric cancer
* Patients who are treated by chemo(radio)therapy or endoscopic submucosal dissection for gastric cancer
* Patients who are diagnosed and treated with other malignancies within 5 years
* Vulnerable patients
* Patients who participating or participated in other clinical trial within 6 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT03385018
Study Brief:
Protocol Section:
NCT03385018